Abstract
Pituitary tumors (PTs) are a heterogeneous group of lesions of the central nervous system that are usually benign. Most of them occur sporadically, but 5% can do so within family syndromes, usually at a young age. There are differences by sex, age, race, and genetic factors in the prevalence of different tumor cell types and clinical presentation. Functioning-PTs (FPTs) are usually diagnosed earlier than non-functioning PTs (NFPTs). However, this depends on the PT type. Headaches and visual disturbances are the most frequent mass-effect symptoms, but seizures or hydrocephalus may also occur. Pituitary apoplexy is another possible mode of presentation, and it requires special attention because of its potential severity. PTs in pregnancy, childhood, and old age present a series of clinical peculiarities that must be taken into account when evaluating these patients. Ectopic PTs (EPTs) are uncommon and share the same clinical-epidemiological data as eutopic PTs, but, depending on their location, other types of clinical manifestations may appear. Silent PTs are often detected as an incidentaloma or due to neurologic symptoms related to mass-effect. Aggressive PTs and pituitary carcinomas (PCs), which are very rare, are characterized by multiple local recurrences and metastases, respectively. This review addresses the epidemiology and clinical presentation of PTs, from the classical hormonal and mass-effect symptoms to the different rare presentations, such as pituitary apoplexy, hydrocephalus, or diabetes insipidus. Moreover, special situations of the presentation of PTs are discussed, namely, PTs in pregnancy, childhood, and the elderly, EPTs, silent and aggressive PTs, and PCs.
Similar content being viewed by others
References
Villa C, Vasiljevic A, Jaffrain-Rea ML et al (2019) A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch. https://doi.org/10.1007/s00428-019-02655-0
Ho KKY, Fleseriu M, Wass J et al (2019) A tale of pituitary adenomas: to NET or not to NET. Pituitary. https://doi.org/10.1007/s11102-019-00988-2
Aflorei ED, Korbonits M (2014) Epidemiology and etiopathogenesis of pituitary adenomas. J Neuro-Oncol. https://doi.org/10.1007/s11060-013-1354-5
Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613–619
Mindermann T, Wilson CB (1994) Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol 41(3):359–364
Beckers A, Daly AF (2007) The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol. https://doi.org/10.1530/EJE-07-0348
Solari D, Pivonello R, Caggiano C, Guadagno E, Chiaramonte C, Miccoli G, Cavallo LM, Del Basso De Caro M, Colao A, Cappabianca P (2019) Pituitary adenomas: what are the key features? What are the current treatments? Where is the future taking us? World Neurosurg 127:695–709. https://doi.org/10.1016/j.wneu.2019.03.049
Alrezk R, Hannah-Shmouni F, Stratakis CA (2017) MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr Relat Cancer. https://doi.org/10.1530/ERC-17-0243
Vasilev V, Daly AF, Petrossians P, Zacharieva S, Beckers A (2011) Familial pituitary tumor syndromes. Endocr Pract 17(Suppl 3):41–46. https://doi.org/10.4158/EP11064.RA
Shaid M, Korbonits M (2017 May-Jun) Genetics of pituitary adenomas. Neurol India 65(3):577–587. https://doi.org/10.4103/neuroindia.NI_330_17
Pepe S, Korbonits M, Iacovazzo D (2019) Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects. J Endocrinol. https://doi.org/10.1530/JOE-18-0446
Drange MR, Fram NR, Herman-Bonert V, Melmed S (2000) Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.85.1.168
Karaca Z, Yarman S, Ozbas I et al (2018) How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey. J Endocrinol Investig. https://doi.org/10.1007/s40618-017-0709-8
Perry A, Graffeo CS, Marcellino C, Pollock BE, Wetjen NM, Meyer FB (2018) Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm. J Neurol Surg Part B Skull Base. https://doi.org/10.1055/s-0038-1625984
Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea ML (2005) Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol. https://doi.org/10.1530/eje.1.02030
Agely A, Okromelidze L, Vilanilam GK, Chaichana KL, Middlebrooks EH, Gupta V (2019) Ectopic pituitary adenomas: common presentations of a rare entity. Pituitary. https://doi.org/10.1007/s11102-019-00954-y
Mayson SE, Snyder PJ (2015) Silent pituitary adenomas. Endocrinol Metab Clin N Am. https://doi.org/10.1016/j.ecl.2014.11.001
Raverot G, Trouillas J, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Dekkers OM (2018 Jan) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1–G24. https://doi.org/10.1530/EJE-17-0796
Lloyd RV, Osamura YR, Kloppel G, Rosai J (2017) WHO classification of tumours of endocrine organs. WHO Press
Nilsson B, Gustavsson-Kadaka E, Bengtsson BÅ, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.85.4.1420
Daly AF, Tichomirowa MA, Beckers A (2009) The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2009.05.008
Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC (1997) Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 314(5):287–291
Yue NC, Longstreth WT, Elster AD, Jungreis CA, O’Leary DH, Poirier VC (1997) Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology. https://doi.org/10.1148/radiology.202.1.8988190
McDowell BD, Wallace RB, Carnahan RM, Chrischilles EA, Lynch CF, Schlechte JA (2011) Demographic differences in incidence for pituitary adenoma. Pituitary. https://doi.org/10.1007/s11102-010-0253-4
Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, Thorsson AV, Carroll PV, Korbonits M, Benediktsson R (2015) The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. Eur J Endocrinol. https://doi.org/10.1530/EJE-15-0189
Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol. https://doi.org/10.1111/j.1365-2265.2009.03667.x
Richard N (1999) Clayton. Sporadic pituitary tumours: from epidemiology to use of databases. Baillieres Best Pract Res Clin Endocrinol Metab 13(3):451–460
Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liège. Belgium J Clin Endocrinol Metab doi. https://doi.org/10.1210/jc.2006-1668
Heshmat MY, Kovi J, Simpson C, Kennedy J, Fan KJ (1976) Neoplasms of the central nervous system. Incidence and population selectivity in the Washington DC, metropolitan area. Cancer. https://doi.org/10.1002/1097-0142(197611)38:5<2135::AID-CNCR2820380543>3.0.CO;2-T
Gittleman H, Ostrom QT, Farah PD et al (2014) Descriptive epidemiology of pituitary tumors in the United States, 2004-2009: clinical article. J Neurosurg. https://doi.org/10.3171/2014.5.JNS131819
Tjörnstrand A, Gunnarsson K, Evert M, et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Eur J Endocrinol. 2014;171(4):519–526
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2010-1692
Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2008-0125
Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, Wass JAH (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2014-2700
Ntali G, Capatina C, Grossman A, Karavitaki N (2014) Functioning gonadotroph adenomas. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2014-2362
Beck-Peccoz P, Persani L, Mannavola D, Campi I (2009) TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2009.05.006
Penn DL, Burke WT, Laws ER (2018) Management of non-functioning pituitary adenomas: surgery. Pituitary. https://doi.org/10.1007/s11102-017-0854-2
Lithgow K, Batra R, Matthews T (2019) Karavitaki N. Management of endocrine disease: visual morbidity in patients with pituitary adenoma. Eur J Endocrinol 181(5):R185–R197. https://doi.org/10.1530/EJE-19-0349
Vié AL, Raverot G (2019) Modern neuro-ophthalmological evaluation of patients with pituitary disorders. Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2019.05.003
Thomas R, Shenoy K, Seshadri MS, Muliyil J, Rao A, Paul P (2002) Visual field defects in non-functioning pituitary adenomas. Indian J Ophthalmol 50(2):127–130
Rizzoli P, Iuliano S, Weizenbaum E, Laws E (2016) Headache in patients with pituitary lesions: a longitudinal cohort study. Neurosurgery. https://doi.org/10.1227/NEU.0000000000001067
Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR (2000) The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.85.5.1789
Levy MJ (2011) The association of pituitary tumors and headache. Curr Neurol Neurosci Rep. https://doi.org/10.1007/s11910-010-0166-7
Turcu AF, Erickson BJ, Lin E, Guadalix S, Schwartz K, Scheithauer BW, Atkinson JLD, Young WF (2013) Pituitary stalk lesions: the mayo clinic experience. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2012-4171
Iglesias P, Rodríguez Berrocal V, Díez JJ (2018) Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine. https://doi.org/10.1007/s12020-018-1645-x
Chentli F, Akkache L, Daffeur K, Azzoug S (2014) General seizures revealing macro-adenomas secreting prolactin or prolactin and growth hormone in men. Indian J Endocrinol Metab. https://doi.org/10.4103/2230-8210.131185
Brisman MH, Fetell MR, Post KD (1993) Reversible dementia due to macroprolactinoma. Case Rep J Neurosurg. https://doi.org/10.3171/jns.1993.79.1.0135
Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Lee Vance M (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2010-1048
Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab. https://doi.org/10.1016/j.beem.2009.05.001
Bills DC, Meyer FB, Laws ER, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33(4):602–608
Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol. https://doi.org/10.1046/j.1365-2265.1999.00754.x
Möller-Goede DL, Brändle M, Landau K, Bernays RL, Schmid C (2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol. https://doi.org/10.1530/EJE-10-0651
Barkhoudarian G, Kelly DF (2019) Pituitary apoplexy. Neurosurg Clin N Am 30(4):457–463. https://doi.org/10.1016/j.nec.2019.06.001
Glezer A, Bronstein MD (2015) Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 59(3):259–264. https://doi.org/10.1590/2359-3997000000047
Hannon AM, O’Shea T, Thompson CA, Hannon MJ, Dineen R, Khattak A et al (2019) Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. Eur J Endocrinol 180(4):K21–K29. https://doi.org/10.1530/EJE-18-0688
Brue T, Amodru V, Castinetti F (2018) Management of Cushing’s syndrome during pregnancy: solved and unsolved questions. Eur J Endocrinol. https://doi.org/10.1530/EJE-17-1058
Hannah-Shmouni F, Stratakis CA (2018) An update on the genetics of benign pituitary adenomas in children and adolescents. Curr Opin Endocr Metab Res. https://doi.org/10.1016/j.coemr.2018.04.002
Fideleff HL, Boquete HR, Sequera A, Suárez M, Sobrado P, Giaccio A (2000) Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. J Pediatr Endocrinol Metab. https://doi.org/10.1515/JPEM.2000.13.3.261
Stratakis CA (2018) An update on Cushing syndrome in pediatrics. Ann Endocrinol (Paris). https://doi.org/10.1016/j.ando.2018.03.010
Joshi SM, Hewitt RJD, Storr HL, Rezajooi K, Ellamushi H, Grossman AB, Savage MO, Afshar F (2005) Cushing’s disease in children and adolescents: 20 years of experience in a single neurosurgical center. Neurosurgery. https://doi.org/10.1227/01.NEU.0000166580.94215.53
Abe T, Tara LA, Ludecke DK (1999) Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery. Neurosurgery 45(1):1–10
Webb C, Prayson RA (2008) Pediatric pituitary adenomas. Arch Pathol Lab Med 132(1):77–80. https://doi.org/10.1043/1543-2165(2008)132[77:PPA]2.0.CO;2
Benbow SJ, Foy P, Jones B, Shaw D, MacFarlane IA (1997) Pituitary tumours presenting in the elderly: management and outcome. Clin Endocrinol. https://doi.org/10.1046/j.1365-2265.1997.1180933.x
Yang BT, Chong VFH, Wang ZC, Xian JF, Chen QH (2010) Sphenoid sinus ectopic pituitary adenomas: CT and MRI findings. Br J Radiol 83(987):218–224. https://doi.org/10.1259/bjr/76663418
Hou L, Harshbarger T, Herrick MK, Tse V, Ciric IS, Maartens NF, Laws ER, Marino R (2002) Suprasellar adrenocorticotropic hormone-secreting ectopic pituitary adenoma: case report and literature review. Neurosurgery. https://doi.org/10.1097/00006123-200203000-00035
Thompson LDR, Seethala RR, Müller S (2012) Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and Immunophenotypic study of 32 cases with a comprehensive review of the English literature. Head Neck Pathol. https://doi.org/10.1007/s12105-012-0336-9
Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2010-0537
Park SH, Jang JH, Lee YM, Kim JS, Kim KH, Kim YZ (2017) Function of cell-cycle regulators in predicting silent pituitary adenoma progression following surgical resection. Oncol Lett. https://doi.org/10.3892/ol.2017.7117
Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156(2):203–216
Ferrante E, Ferraroni M, Castrignanò T et al (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. https://doi.org/10.1530/eje.1.02298
Baldeweg SE, Pollock JR, Powell M, Ahlquist J (2005) A spectrum of behaviour in silent corticotroph pituitary adenomas. Br J Neurosurg. https://doi.org/10.1080/02688690500081230
Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, Laws ER, Young WF (2000) Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery. https://doi.org/10.1227/00006123-200009000-00039
Langlois F, Woltjer R, Cetas JS, Fleseriu M (2018) Silent somatotroph pituitary adenomas: an update. Pituitary. https://doi.org/10.1007/s11102-017-0858-y
Kim JS, Lee YS, Jung MJ, Hong YK (2016) The predictive value of pathologic features in pituitary adenoma and correlation with pituitary adenoma recurrence. J Pathol Transl Med. https://doi.org/10.4132/jptm.2016.06.30
Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF, Lloyd RV, Davis DH, Guthrie BL, Schoene WC (1997) Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer. https://doi.org/10.1002/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3
McCormack A, Dekkers OM, Petersenn S et al (2018) Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol. https://doi.org/10.1530/EJE-17-0933
Lenders N, McCormack A (2018) Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma). Pituitary. https://doi.org/10.1007/s11102-017-0857-z
Yang Z, Zhang T, Gao H (2016) Genetic aspects of pituitary carcinoma: a systematic review. Med (United States). https://doi.org/10.1097/MD.0000000000005268
Dworakowska D, Grossman AB (2018) Aggressive and malignant pituitary tumours: state-of-the-art. Endocr Relat Cancer. https://doi.org/10.1530/ERC-18-0228
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Araujo-Castro, M., Berrocal, V.R. & Pascual-Corrales, E. Pituitary tumors: epidemiology and clinical presentation spectrum. Hormones 19, 145–155 (2020). https://doi.org/10.1007/s42000-019-00168-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-019-00168-8